Cognigenics is a startup based in the United Kingdom, most recent round Pre-Seed, 1 tracked investor.
Based in the United Kingdom, Cognigenics is a startup founded in 2019. Its most recent tracked round is Pre-Seed. Brouky records 1 investor associated with the company.
Cognigenics is a biotechnology company developing RNA-based therapeutics for mood disorders, memory loss, and cognitive impairment through non-invasive, intranasal delivery of siRNA.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.